Skip to main content
CHEIL BIO CO., LTD. logo

CHEIL BIO CO., LTD. — Investor Relations & Filings

Ticker · 052670 ISIN · KR7052670007 KO Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2019-03-11 Regulatory Filings
Country KR South Korea
Listing KO 052670

About CHEIL BIO CO., LTD.

http://www.cheilbio.com/en/index.php

CHEIL BIO CO., LTD. is a company that develops, manufactures, and markets a wide range of advanced veterinary products. The company focuses on improving the health and productivity of livestock through solutions based on extensive research and biotechnology. Its core offerings include animal medicines, such as antibiotics and antimicrobials, and functional feed additives. These products cater to a diverse market, including the swine, poultry, cattle, and aquaculture sectors, as well as companion animals. The company leverages its dedicated research and development capabilities to create high-quality, market-competitive products and aims to achieve global technological competitiveness in the animal health industry.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
Regulatory Filings Classification · 95% confidence The document is a formal notification filed with the Korea Exchange (KRX) regarding the reason for holding a General Meeting of Shareholders on a 'concentrated date' (a date when many companies hold their AGMs). It explains the scheduling conflict and provides details about the meeting date and the company's compliance efforts. Since it is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2019-03-11 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Cheilbio. It contains the meeting agenda, director information, and financial statements (balance sheet, etc.) to be approved by shareholders. This type of document is standard for providing information to shareholders prior to an AGM and is classified as Proxy Solicitation & Information Statement (PSI) in the provided schema.
2019-03-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Jeil Bio) announcing a significant change (over 15-30%) in financial performance (revenue, operating profit, net income) compared to the previous fiscal year. This is a standard 'Earnings Release' (ER) filing, which provides preliminary financial highlights before the final audited annual report is published. FY 2018
2019-03-07 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company 'Jeil Bio'. It outlines the date, time, location, and the agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and remuneration limits. This document serves as the official proxy solicitation and information statement provided to shareholders prior to the meeting.
2019-03-07 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or meeting materials, but rather serves as a formal notice of a corporate action. Given it is a regulatory announcement that does not fit into specific categories like dividend or share issuance, it falls under the general regulatory filing category.
2018-12-13 Korean
분기보고서 (2018.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Cheilbio Co., Ltd.' (주)제일바이오, covering the period from January 1, 2018, to September 30, 2018. It contains detailed financial information, business descriptions, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.